FundedIQ
Biotechnology

Spiral Therapeutics: Funding, Investors & Team (Sep 2026)

A pharmaceutical business in the clinical stages, Spiral Therapeutics provides cutting-edge treatments for hearing loss. Its platform treats hearing loss by dispensing the appropriate medication at the appropriate time and location.

www.spiraltx.com San Francisco, United States 11-50 employees
Biotechnology Health Care Medical Pharmaceutical B2B
Total raised
$35.3M
Rounds
2
Latest
Series B
Apr 2026

Spiral Therapeutics has raised $35.3M across 2 funding rounds on record, the most recent a Series B of $27.0M announced in Apr 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Spiral Therapeutics Company Profile and Key Stats

Total funding raised
$35.3M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$27.0M in Apr 2026
Employees
11-50
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Apr 2026.

Spiral Therapeutics Funding Rounds

Date
Round
Amount
Series B
$27.0M
Undisclosed round
$8.3M

Spiral Therapeutics raised $8.3M in an undisclosed round announced in Jan 2023.

3.3 years later, a Series B of $27.0M was announced in Apr 2026.

Spiral Therapeutics Founders and Leadership Team

Name
Role
Contact
Hugo Peris
CEO
Locked

Contact details for the Spiral Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Spiral Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
4,289
$30M

Spiral Therapeutics' latest round of $27.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Spiral Therapeutics in Biotechnology and San Francisco

Companies Similar to Spiral Therapeutics

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Spiral Therapeutics Funding FAQs

What does Spiral Therapeutics do?

A pharmaceutical business in the clinical stages, Spiral Therapeutics provides cutting-edge treatments for hearing loss. Its platform treats hearing loss by dispensing the appropriate medication at the appropriate time and location.

How much funding has Spiral Therapeutics raised?

Spiral Therapeutics has raised $35.3M across 2 rounds on record. The most recent is a Series B of $27.0M announced in Apr 2026.

When did Spiral Therapeutics last raise funding?

Spiral Therapeutics' most recent funding round on record is a Series B of $27.0M, announced in Apr 2026.

Who is the CEO of Spiral Therapeutics?

Hugo Peris is listed as CEO at Spiral Therapeutics.

Where is Spiral Therapeutics headquartered?

Spiral Therapeutics is based in San Francisco, California, United States.

How many employees does Spiral Therapeutics have?

Spiral Therapeutics is in the 11-50 employee band.

How does Spiral Therapeutics' funding compare to other Biotechnology startups?

Spiral Therapeutics' latest round of $27.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Spiral Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Spiral Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.